Anti-C1q autoantibodies, novel tests, and clinical consequences.
about
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune DiseasesComplement System Part II: Role in ImmunityAnti-C1q Antibody is Associated with Renal and Cutaneous Manifestations in Asian Indian Patients with Systemic Lupus Erythematosus.Reflections on Lupus 2013: butterflies, wolves and prophecies.The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy.Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosusAntibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus NephritisCorrelation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus.Evaluation of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Discriminating between Active and Non-Active Systemic Lupus ErythematosusThe complement system in systemic lupus erythematosus: an update.The complement system as a potential therapeutic target in rheumatic disease.C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis.The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity.Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis.Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.Anti-C1q in systemic lupus erythematosus.Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.Interpretation of Serological Complement Biomarkers in Disease
P2860
Q26766486-5436A926-FF06-47F9-B853-2156B36C0260Q28263460-C410874B-B604-46B5-A487-19554223BF79Q33666607-9FEC1A43-EC1E-4875-9AA4-5062F6651EDCQ34976836-48BADACF-BB02-4851-8C88-EDA04A2F0C1CQ35169740-409AC8FF-7D03-4781-8254-C7A0D061AFD4Q35825371-EA4A8B91-F2B4-424D-A487-114C3440C235Q36208980-A49839DB-D18D-449E-B6A0-5B24188B6F61Q36741210-8AA19E2B-3AD1-4D6B-A17F-57B69175F737Q37069721-0B445FAB-211F-48FF-8B3F-3E831A349086Q38213193-3DB3765F-4D20-432E-BEEE-02FF25852712Q38631542-0B00A484-98C1-40AD-BBEB-D8128C9877C3Q39272808-6407662C-FFF0-4FD1-B03C-C0258E2BCEC1Q39646545-554A4864-81AE-43D6-8E30-5495BEC01AEAQ50448184-FA48C7DA-FBE8-4AC2-9A51-D5EBC4AB582FQ51724929-426191FC-38E5-4BAA-A080-8EA63A80EA49Q51724933-4E4A22CF-6FE5-47D8-8424-91522E03A7C9Q52310243-62E6A817-69C9-47A9-94CE-AA635E514A9BQ58566667-B82A4108-58FE-4595-BD91-5B4C941889F4
P2860
Anti-C1q autoantibodies, novel tests, and clinical consequences.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-C1q autoantibodies, novel tests, and clinical consequences.
@en
type
label
Anti-C1q autoantibodies, novel tests, and clinical consequences.
@en
prefLabel
Anti-C1q autoantibodies, novel tests, and clinical consequences.
@en
P2860
P356
P1476
Anti-C1q autoantibodies, novel tests, and clinical consequences.
@en
P2093
Rosanne A van Schaarenburg
P2860
P356
10.3389/FIMMU.2013.00117
P577
2013-05-14T00:00:00Z